GlassScriptPhysician profile
Megan C Jack
NPI 1093934341
$7,037.71
in general payments reported to CMS, 2019-2025
23 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $504 · 2021: $645 · 2022: $545 · 2023: $347 · 2024: $4,223 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,184 · Food and Beverage: $1,921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,183.76 |
| Food and Beverage | $1,921.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,012.69 | 2023-2025 | |
| Mentor Worldwide LLC | $1,367.28 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $398.74 | 2020-2022 | |
| Sientra, INC. | $328.69 | 2020-2022 | |
| Motiva USA, LLC | $300.04 | 2025 | |
| Revance Therapeutics, INC. | $114.37 | 2024 | Daxxify |
| Avita Medical Americas, LLC | $55.05 | 2024 | |
| Merz North America, INC. | $50.82 | 2019-2022 | |
| Apyx Medical Corporation | $48.93 | 2019 | |
| Epi Health, LLC | $46.64 | 2019-2020 | |
| Galderma Laboratories, L.P. | $44.60 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.84 | 2019 | |
| Tela Bio, INC. | $35.41 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $29.22 | 2025 | |
| Almirall LLC | $23.62 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Promius Pharma LLC | $23.58 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $22.71 | 2024 | Iovera, Exparel |
| Kci USA, INC. | $19.76 | 2023 | Cavilon, Promogran Prisma, Activ.A.C. |
| Mayne Pharma Commercial LLC | $19.21 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $18.91 | 2024 | |
| Bard Peripheral Vascular, INC. | $15.45 | 2021 | |
| Coopersurgical, INC. | $11.12 | 2021 | |
| Merck Sharp & Dohme LLC | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Jack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.